The Martin University Hospital is a Slovak public university hospital located in the Martin municipality, in the county of Zilina, north-east of the Slovak capital Bratislava. It is a teaching hospital and it is the main university hospital affiliated with the Jessenius School of Medicine.

There are 900 beds in Univerzitna nemocnica Martin.

During the past decade, Univerzitna nemocnica Martin conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 11 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Univerzitna nemocnica Martin" #1 sponsor was "Pfizer" with 8 trials, followed by "Ferring Pharmaceuticals" with 2 trials sponsored, "Société des Produits Nestlé (SPN)" with 2 trials sponsored, "ALK-Abelló A/S" with 1 trials sponsored and "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Univerzitna nemocnica Martin" #1 collaborator was "Astellas Pharma Inc" with 4 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 4 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Epidemiological and Clinical Research Information Network" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Univerzitna nemocnica Martin" are "Prostate Cancer" (6 trials), "Cancer of the Prostate" (2 trials), "Hereditary Angioedema" (2 trials), "Multiple Sclerosis" (2 trials) and "Allergy" (1 trials). Many other conditions were trialed in "Univerzitna nemocnica Martin" in a lesser frequency.

Most popular intervention types in "Univerzitna nemocnica Martin" are "Drug" (19 trials), "Other" (5 trials), "Biological" (4 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Enzalutamide" (4 trials), "Leuprolide" (2 trials), "Mavenclad®" (2 trials) and "Abiraterone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Univerzitna nemocnica Martin" are 21 trials for "All" genders, 8 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Univerzitna nemocnica Martin". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Univerzitna nemocnica Martin, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Univerzitna nemocnica Martin, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".

Univerzitna nemocnica Martin has several departments that took part in Clinical trials: "Klinika hematologie a transfuziologie, Univerzitna nemocnica Martin" - 2 trials